Comparison of native vs pegylated asparaginase for HR Ph chromosome-negative ALL
Highlights from ASH 2016: whole-genome sequencing to identify genomic lesions in ALL
Benefits of early therapeutic intervention for high-risk smouldering multiple myeloma patients
Allogeneic transplant in multiple myeloma: who should receive it and the future of transplant
Heinz Ludwig et al.
Smouldering myeloma: detection, risk stratification and defining a new standard of care
What is the role of allogeneic stem cell transplantation in CLL in the light of novel drugs?